Dec 10, 2020

Advanced Bionics Receives FDA Approval for Marvel Cochlear Implant Platform and World’s First Sound Processor for Children


Collaboration with Phonak brings breakthrough Marvel hearing technology to adult and pediatric cochlear implant wearers

VALENCIA, Calif., USA, December 10, 2020– Advanced Bionics (AB), a global leader in cochlear implant technology, in collaboration with Phonak, a leading provider of life-changing hearing solutions, receives FDA approval and announces it is bringing Marvel hearing technology to Advanced Bionics cochlear implant wearers.


 This includes:

  • Sky CI™ Marvel, the world’s first dedicated sound processor for children
  • New Naída™ CI Marvel sound processor for adults
  • Sky Link Marvel and Naida Link Marvel super-power hearing aids for bimodal wearers
  • New Target CI fitting software with industry-first features
  • New Advanced Bionics Remote app for easy adjustments via smartphone

Naída CI Marvel offers wearers a powerful hearing experience with effortless comfort and convenience

With its more than 25 years of experience in cochlear implants, Advanced Bionics brings the celebrated Marvel platform to benefit their adult cochlear implant recipients. With AutoSense OS™ 3.0, Naída CI Marvel delivers excellent sound quality and performance in a variety of situations throughout the day. This machine-learning algorithm analyzes the sounds in the listener’s environment every 0.4 seconds and can identify whether they’re in a noisy restaurant, car, concert hall, at home, etc. It then engages the appropriate cochlear implant system features to customize and enhance the wearer’s hearing experience based on the specific characteristics of the listening environment.

With Marvel CI, Advanced Bionics offers the world’s first cochlear implant sound processor to connect to virtually any Bluetooth-enabled device and to support hands-free calling. Naída CI Marvel’s unique ergonomic housing and slim headpiece offer a secure, discreet, and comfortable wearing experience. Together with the AB remote app, which enables convenient and discreet management of the hearing devices, it provides ultimate ease of use.
 

Sky CI Marvel is the world’s first dedicated sound processor for children

 Sky CI Marvel combines proven Advanced Bionics sound processing with the proven Marvel platform from Phonak, a global leader in pediatric hearing care. AutoSense Sky OS™ 3.0 work similarly to the adult version in Naida CI Marvel but is uniquely designed for a child’s typical listening situations, providing excellent sound quality and performance wherever the child goes.

Offering a wide variety of wearing options, child-preferred colors, and waterproof accessories, Sky CI Marvel offers flexibility for a growing child’s adventures, whether at the pool or in school. Its integrated Roger™ technology help kids hear their teachers and conversation partners in classrooms, cafeterias, and auditoriums directly in their ears, bypassing noise in the environment. Plus, direct smartphone connectivity via Bluetooth® and the intuitive AB Remote app help kids stay connected with the world around them throughout their day.
 

Dynamic Bimodal Hearing with Sky Link Marvel and Naida Link Marvel

Most cochlear implant wearers choose to a have only one cochlear implant despite having severe or profound hearing loss in both ears. The other un-implanted ear requires a super-powered hearing solution that works in harmony with the cochlear implant. This is known as bimodal hearing, and scientific evidence shows that combining a hearing aid with a cochlear implant results in significantly higher speech understanding and sound quality than provided by the cochlear implant or a hearing aid alone.*

Marvel technology has now been extended to these bimodal-hearing patients with the introduction of Phonak Sky Link Marvel and new Naida Link Marvel. Both the Sky Link Marvel and Naida Link Marvel can be worn together as hearing aids or be paired with an Advanced Bionics Sky CI Marvel or Naida CI Marvel sound processor. Because they are both based on Marvel technology, the cochlear implant sound processor and hearing aid are wirelessly connected and communicate with each other in a coordinated, dynamic way. Like their cochlear implant counterparts, both Sky Link Marvel and Naida Link Marvel also feature RogerDirect™, hands-free calls with own voice-pickup, and directly connect to iOS, Android or other Bluetooth-enabled devices.

“This is one of the most important and impressive product launches Advanced Bionics has ever had. Building on the wildly successful Phonak Marvel platform, Naída CI Marvel, Sky CI Marvel, and Target CI are going to be game changers for the cochlear implant industry, revolutionizing the way our wearers can expect to hear with their cochlear implant systems, and the way their hearing care providers fit them,” stated Victoria E. Carr-Brendel, Ph.D., GVP, Sonova Group and President of Advanced Bionics.

“The relationship between Phonak and Advanced Bionics is more than just a collaboration – it’s truly a partnership among two sister brands that share Sonova’s vision of a world where everyone enjoys the delight of hearing and lives a life without limitations,” added Sandy Brandmeier, President of Sonova USA’s Wholesale Hearing Instruments division. “Marvel was Phonak’s most successful product launch in history and we couldn’t be prouder to offer that technology to bimodal wearers as well as those preparing for cochlear implants with Naida Link Marvel and Sky Link Marvel.”
 

Target CI Marvel is designed to offer hearing care professionals easier, faster, and smarter fittings.

Target CI offers hearing care professionals easier fittings with the industry-standard Noahlink Wireless, giving them and their patients the freedom and convenience of cable-free programming. For the first time ever, professionals can program a cochlear implant and the associated bimodal hearing aid with one software in one fitting session. Its intuitive workflow, and user-centric design and features are made for faster fittings, allowing professionals to spend more time with their patients, rather than the software. Target CI is also designed to be a smarter fitting tool, with default settings optimized for cochlear implant patients, giving professionals the flexibility to meet their patient-specific needs.

“My hearing aid research studies have shown that AutoSense technology provides significant improvement in hearing in many challenging real world listening situations. I’m pleased to see this kind of innovation available in the Marvel CI to allow adult and pediatric CI patients to connect with the world around them more easily than ever before. Target CI’s integration with the Noah software system and Noahlink Wireless will also add a great deal of efficiency for clinicians working with cochlear implants,” said Jace Wolfe, Ph.D., Chief of Audiology & Research, Hearts for Hearing.

For more information, please visit advancedbionics.com or www.phonak.com or www.phonakpro.com.


Media Relations Contact

Advanced Bionics LLC
Charlotte Séguy
Phone: +41 79 678 26 30
Email: charlotte.seguy@advancedbionics.com

Phonak US
John Urbaniak
Phone: +1 331-204-2799
Email: john.urbaniak@sonova.com

Phonak Global
Florence Camenzind
Phone: +41 79 378 71 31
Email:
Florence.camenzind@phonak.com


About Advanced Bionics

Advanced Bionics is a global leader in developing hearing solutions for individuals with severe-to-profound hearing loss who no longer benefit from hearing aids. Founded in 1993 and a subsidiary of the Sonova Group since 2009, AB develops cutting-edge cochlear implant technology that allows recipients to hear their best. AB joined Phonak as part of the Sonova Group of companies and began a collaboration unlike any other in the industry. Since then, the innovation leaders in cochlear implants and hearing aids have continuously combined technologies to deliver new, unequalled hearing solutions.

With sales in more than 50 countries and a proven track record for developing high-performing, state-of-the-art products, AB’s talented worldwide group of technologists and professionals are driven to engage with patients and professionals, work with integrity, and stay firmly committed to the best possible performance. 
 

About Phonak

Headquartered near Zurich, Switzerland, Phonak, a member of the Sonova Group, was created in 1947 out of a passion for taking on the most difficult hearing challenges. Seventy years later, this passion remains. As one of the industry’s leading innovator, we offer the broadest portfolio of life-changing hearing solutions. From pediatric to profound hearing loss, we remain committed to creating hearing solutions that change people’s lives to thrive socially and emotionally. We believe in creating a world where ‘Life is on’ for everyone.

At Phonak, we believe that well-hearing equates to well-being and is essential to living life to the fullest. For more than 70 years, we have remained passionate about creating a world where ‘life is on’ for everyone. Our innovative hearing solutions are designed for people of all ages and all degrees of hearing loss, to connect socially, thrive mentally and grow emotionally. Life is on. 
 

The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Sonova AG is under license.

* Gifford, R. H., and Dorman, M. F. (2019). Bimodal hearing or bilateral cochlear implants: ask the patient. Ear and Hearing, 40(3), 501-516. doi: 10.1097/AUD.0000000000000657.

 

Read more
May 27, 2020

Advanced Bionics awarded damages in patent infringement lawsuit

Stäfa (Switzerland), May 19, 2020 –Sonova Holding AG, a leading provider of hearing solutions, announces today that on May 18, 2020 the United States Court of Appeals for the Federal Circuit has denied the petition by Cochlear Ltd. (Cochlear) for an en banc review of the Court’s earlier judgement, with which it affirmed a verdict in the patent infringement lawsuit by the Alfred E. Mann Foundation for Scientific Research (AMF) and Advanced Bionics LLC (AB) v. Cochlear. The court thereby ultimately confirmed the earlier judgement and that Cochlear willfully infringed two patents, and confirmed the awarded damages of USD 268 million, plus interest. As a co-plaintiff, AB is entitled to a share of the damages awarded, after deduction of certain costs for the proceedings. Sonova expects that the verdict will result in a one-time income of around CHF 100- 120 million in FY 2020/21. A motion by AMF and AB for pre-trial interest is still pending a ruling by the District Court.


The lawsuit concerned two patents owned by AMF related to technology for cochlear implants. The lawsuit was filed by AMF back in 2007. AB exclusively licensed the two patents from AMF and for that reason was brought in at a later date as a necessary party. The patents in question have since expired.
 

Contacts:

Investor Relations
Thomas Bernhardsgrütter
Phone: +41 58 928 33 44
Mobile: +41 79 618 28 07  
Email: thomas.bernhardsgruetter@sonova.com

Media Relations
Patrick Lehn
Phone: +41 58 928 33 23
Mobile: +41 79 410 82 84
Email: patrick.lehn@sonova.com

Disclaimer

This Media Release contains forward-looking statements, which offer no guarantee with regard to future performance. These statements are made on the basis of management’s views and assumptions regarding future events and business performance at the time the statements are made. They are subject to risks and uncertainties including, but not confined to, future global economic conditions, exchange rates, legal provisions, market conditions, activities by competitors and other factors outside Sonova’s control. Should one or more of these risks or un- certainties materialize or should underlying assumptions prove incorrect, actual outcomes may vary materially from those forecasted or expected. Each forward-looking statement speaks only as of the date of the particular statement, and Sonova undertakes no obligation to publicly update or revise any forward-looking statements, except as required by law.

About Sonova

Sonova, headquartered in Stäfa, Switzerland, is a leading provider of innovative hearing care solutions. The Group operates through its core business brands Phonak, Unitron, Hansaton, Advanced Bionics and AudioNova. Sonova offers its customers one of the most comprehensive product portfolios in the industry – from hearing instruments to cochlear implants to wireless communication solutions.

Pursuing a unique vertically integrated business strategy, the Group operates through three core businesses – hearing instruments, audiological care and cochlear implants – along the entire value chain of the hearing care market. The Group’s sales and distribution network, the widest in the industry, comprises over 50 own wholesale companies and more than 100 independent distributors. This is complemented by Sonova’s audiological care business, which offers professional audiological services through a network of around 3,500 locations in 19 key markets.

Founded in 1947, the Group has a workforce of over 15,000 dedicated employees and generated sales of CHF 2.92 billion in the financial year 2019/20 as well as a net profit of CHF 490 million. Across all businesses, and by supporting the Hear the World Foundation, Sonova pursues its vision of a world where everyone enjoys the delight of hearing and therefore lives a life without limitations.

For more information please visit www.sonova.com and www.hear-the-world.com.

Sonova shares (ticker symbol: SOON, Security no: 1254978, ISIN: CH0012549785) have been listed on the SIX Swiss Exchange since 1994. The securities of Sonova have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”), or under the applicable securities laws of any state of the United States of America, and may not be offered or sold in the United States of America except pursuant to an exemption from the registration requirements under the U.S. Securities Act and in compliance with applicable state securities laws, or outside the United States of America to non-U.S. Persons in reliance on Regulation S under the U.S. Securities Act.

Read more
May 27, 2020

Advanced Bionics awarded damages in patent infringement lawsuit

Stäfa (Switzerland), May 19, 2020 –Sonova Holding AG, a leading provider of hearing solutions, announces today that on May 18, 2020 the United States Court of Appeals for the Federal Circuit has denied the petition by Cochlear Ltd. (Cochlear) for an en banc review of the Court’s earlier judgement, with which it affirmed a verdict in the patent infringement lawsuit by the Alfred E. Mann Foundation for Scientific Research (AMF) and Advanced Bionics LLC (AB) v. Cochlear. The court thereby ultimately confirmed the earlier judgement and that Cochlear willfully infringed two patents, and confirmed the awarded damages of USD 268 million, plus interest. As a co-plaintiff, AB is entitled to a share of the damages awarded, after deduction of certain costs for the proceedings. Sonova expects that the verdict will result in a one-time income of around CHF 100- 120 million in FY 2020/21. A motion by AMF and AB for pre-trial interest is still pending a ruling by the District Court.


The lawsuit concerned two patents owned by AMF related to technology for cochlear implants. The lawsuit was filed by AMF back in 2007. AB exclusively licensed the two patents from AMF and for that reason was brought in at a later date as a necessary party. The patents in question have since expired.
 

Contacts:

Investor Relations
Thomas Bernhardsgrütter
Phone: +41 58 928 33 44
Mobile: +41 79 618 28 07  
Email: thomas.bernhardsgruetter@sonova.com

Media Relations
Patrick Lehn
Phone: +41 58 928 33 23
Mobile: +41 79 410 82 84
Email: patrick.lehn@sonova.com

Disclaimer

This Media Release contains forward-looking statements, which offer no guarantee with regard to future performance. These statements are made on the basis of management’s views and assumptions regarding future events and business performance at the time the statements are made. They are subject to risks and uncertainties including, but not confined to, future global economic conditions, exchange rates, legal provisions, market conditions, activities by competitors and other factors outside Sonova’s control. Should one or more of these risks or un- certainties materialize or should underlying assumptions prove incorrect, actual outcomes may vary materially from those forecasted or expected. Each forward-looking statement speaks only as of the date of the particular statement, and Sonova undertakes no obligation to publicly update or revise any forward-looking statements, except as required by law.

About Sonova

Sonova, headquartered in Stäfa, Switzerland, is a leading provider of innovative hearing care solutions. The Group operates through its core business brands Phonak, Unitron, Hansaton, Advanced Bionics and AudioNova. Sonova offers its customers one of the most comprehensive product portfolios in the industry – from hearing instruments to cochlear implants to wireless communication solutions.

Pursuing a unique vertically integrated business strategy, the Group operates through three core businesses – hearing instruments, audiological care and cochlear implants – along the entire value chain of the hearing care market. The Group’s sales and distribution network, the widest in the industry, comprises over 50 own wholesale companies and more than 100 independent distributors. This is complemented by Sonova’s audiological care business, which offers professional audiological services through a network of around 3,500 locations in 19 key markets.

Founded in 1947, the Group has a workforce of over 15,000 dedicated employees and generated sales of CHF 2.92 billion in the financial year 2019/20 as well as a net profit of CHF 490 million. Across all businesses, and by supporting the Hear the World Foundation, Sonova pursues its vision of a world where everyone enjoys the delight of hearing and therefore lives a life without limitations.

For more information please visit www.sonova.com and www.hear-the-world.com.

Sonova shares (ticker symbol: SOON, Security no: 1254978, ISIN: CH0012549785) have been listed on the SIX Swiss Exchange since 1994. The securities of Sonova have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”), or under the applicable securities laws of any state of the United States of America, and may not be offered or sold in the United States of America except pursuant to an exemption from the registration requirements under the U.S. Securities Act and in compliance with applicable state securities laws, or outside the United States of America to non-U.S. Persons in reliance on Regulation S under the U.S. Securities Act.

Read more
Mar 20, 2020

Covid19 Update


Dear AB Family:

Amidst the disruption and uncertainty related to COVID-19, the health and safety of our recipients, hearing care providers, and employees are of the utmost importance to us. Our doors remain open and we are doing our best to make sure that we can maintain strong support for each of you.


We have implemented measures to ensure that we can continue to serve you while doing our part to follow health organization guidelines and best practices to minimize the spread of the virus including social distancing and frequent hand washing. We are regularly cleaning and disinfecting our facilities and equipment.

Our customer service team is ready to serve you or answer questions. Please call us at 877-829-0026. As always, you can shop for products and find information on myABonline.com.

The impact of COVID-19 is changing daily as are the best practices for companies and businesses during this challenging time. We will be monitoring the ongoing situation and follow the advice of the health authorities, governments and the WHO.

Our hearts go out to all those impacted, and we wish you great health through this unprecedented crisis.

All of us at Advanced Bionics
 

Read more
Jul 11, 2019

Advanced Bionics Introduces New Wireless Connectivity Accessory: The leader in cochlear implants releases new wireless receiver to connect their wearers with the world simply and seamlessly.

 
Valencia, CA, July 11, 2019 – Advanced Bionics (AB) demonstrates its commitment to enriching the lives of their wearers with the release of the new Naída™ CI Connect receiver in Canada.

Hands-free phone calls and direct audio streaming are a part of everyday modern life that cochlear implant wearers should enjoy too. Naída CI Connect, one of the most exciting innovations Advanced Bionics developed together with Phonak, is an elegant, design-integrated solution which turns the Naída CI Q90 sound processor into a Bluetooth® wireless headset. With built in microphones for hands-free calling, and compatibility with virtually all Bluetooth-enabled tablets, laptops, and MP3 players, the Naída CI Connect allows cochlear implant wearers to take hands-free phone calls and stream audio directly from virtually any device.

“We are excited about the introduction of Naída CI Connect because we are committed to supporting every Advanced Bionics implant wearer as well as new customers along their hearing journey. For us, this journey doesn’t end as soon as the implant is activated. Our goal is not only to bring our CI wearers into the world of sound, but also to empower them to enjoy their lives to the fullest. And this second part is what the Naida CI Connect is about. This is also the first product we’re launching in 2019, and we’re thrilled about where we’re headed. You can bet on seeing more from us as the year unfolds,” stated Victoria Carr-Brendel, Ph.D., Group Vice President Cochlear Implants (CI), Sonova. 
 

About Advanced Bionics

Advanced Bionics is a global leader in developing hearing solutions for individuals with severe-to-profound hearing loss who no longer benefit from hearing aids. Founded in 1993 and a subsidiary of the Sonova Group since 2009, AB develops cutting-edge cochlear implant technology that allows recipients to hear their best. AB joined Phonak as part of the Sonova Group of companies and began a collaboration unlike any other in the industry. Since then, the innovation leaders in cochlear implants and hearing aids have continuously combined technologies to deliver new, unequalled hearing solutions.

With sales in more than 50 countries and a proven track record for developing high-performing, state-of-the-art products, AB’s talented worldwide group of technologists and professionals are driven work with integrity, engage with patients and professionals, and stay firmly committed to the best possible performance. 
 

Bluetooth® is a registered trademark owned by the Bluetooth SIG, Inc    
 

Media Contact

Olivia Duarte
Advanced Bionics
661.362.1400
MediaInquiries@AdvancedBionics.com

Read More
Jul 10, 2019

Advanced Bionics Launches Active Insertion Monitoring (AIM) System: an innovative monitoring solution for implant surgery and post-op

 
Valencia, CA, July 10, 2019 – Advanced Bionics (AB) unveils its latest powerful innovation, the AIM™ System, at CI2019, the 16th Symposium on Cochlear Implants in Children in Hollywood, Florida. AIM stands for Active Insertion Monitoring, and is designed to be an invaluable tool for surgeons and hearing care professionals working with cochlear implant patients.

Real-time ECochG monitoring during electrode insertion

The challenge with CI surgery today is that surgeons have no objective means of monitoring the function of the cochlea during electrode insertion. The AIM system addresses this issue by using the implant to record ECochG, a proven1 measure of cochlear health, during insertion. ECochG, or electrocochleography, is a technique for recording potentials generated by the inner ear and the auditory nerve in response to acoustic stimulation. Utilizing the advanced measurement capabilities of the AB implant technology, AIM is able to measure ECochG potentials in real-time and provide feedback to the surgeon during electrode insertion.

Objective audiometry and other measurements without patient collaboration

The AIM system continues to offer benefits after the surgery. It can be used to perform objective audiometry from 250 Hz to 4000 Hz quickly and reliably without patient collaboration, making it especially convenient when working with younger and harder-to-test patients. In addition to audiometry, the AIM system can also perform a suite of objective measures including NRI, ESRT, and electrode impedances. All of these tests can be performed quickly and automatically with the click of a button.

Fast, objective, convenient

For all its versatile functionality, AIM is easy to use with its modern and intuitive user interface. After testing, patient data and results can be exported easily, and a full PDF report is generated automatically. In other words, the AIM system is fast, objective, and convenient.

“We’re very excited about the introduction of the AIM system because we believe that this is an important innovation for CI surgery. Surgeons and audiologists want the best outcomes for their patients, and AIM can be a means for them to achieve that. It is another testament to AB’s commitment not only to our CI wearers, but also to the hearing health professionals who care for them,” stated Victoria E. Carr-Brendel, Ph.D., GVP, Sonova Group and President of Advanced Bionics.
 

About Advanced Bionics

Advanced Bionics is a global leader in developing hearing solutions for individuals with severe-to-profound hearing loss who no longer benefit from hearing aids. Founded in 1993 and a subsidiary of the Sonova Group since 2009, AB develops cutting-edge cochlear implant technology that allows recipients to hear their best. AB joined Phonak as part of the Sonova Group of companies and began a collaboration unlike any other in the industry. Since then, the innovation leaders in cochlear implants and hearing aids have continuously combined technologies to deliver new, unequalled hearing solutions.

With sales in more than 50 countries and a proven track record for developing high-performing, state-of-the-art products, AB’s talented worldwide group of technologists and professionals are driven to engage with patients and professionals, work with integrity, and stay firmly committed to the best possible performance.
 

Media Contact

Olivia Duarte
Advanced Bionics
661.362.1400
MediaInquiries@AdvancedBionics.com

 

1. Eggermont JJ (2017). Ups and Downs in 75 Years of Electrocochleography. Front Syst Neurosci; Jan 24, 11(2): eCollection.

Read More
Jun 05, 2019

Advanced Bionics announces that their patented HiRes™ Ultra 3D Cochlear Implant has been awarded the Medtech Breakthrough Award 2019 for Best Overall Medical Device Solution.

 
Valencia, CA, June 5, 2019 – Advanced Bionics (AB) announces that their patented HiRes™ Ultra 3D Cochlear Implant has been awarded the Medtech Breakthrough Award 2019 for Best Overall Medical Device Solution.
Built on the HiRes™ Ultra platform and developed by the internal Research and Development Team at AB, the new implant is the Hassle Free and Pain Free choice for recipients who may need to undergo MRI examinations at some point during their lifetime. Even for high resolution MRI scans, there is no need to surgically remove the new multi-magnet assembly and no requirement for head bandaging, meaning no hearing downtime for the patient. 

“We are proud and grateful to receive this prestigious award for the Best Overall Medical Device Solution,” says Victoria Carr-Brendel, PhD, Group Vice President Cochlear Implants (CI), Sonova. “It is a resounding recognition of the ingenuity and hard work of the people at Advanced Bionics over the last years. The new magnet technology in our Ultra 3D implants is improving the quality of life for many of our CI wearers, making MRI scans a hassle-free and pain-free experience.”

The innovative Ultra 3D multi-magnet assembly is capable of aligning with the magnetic field of the MRI scanner irrespective of patient orientation or movement. This allows adult and pediatric cochlear implant wearers to safely undergo high-resolution imaging, such as 3.0 Tesla MRIs, without surgery or head bandaging, without feeling pain or discomfort, and without restrictions to the orientation of the head during the MRI procedure.

MRI examinations are becoming increasingly commonplace as a diagnostic tool for a wide variety of medical conditions. Prior to the development of MRI-compatible CI magnet technology, wearers and healthcare professionals had to contend with the magnetic field from MRI machines exerting force on the CI magnet inside the head, causing torque and subsequent pain. Although these problems were managed to some extent using head bandaging and/or careful alignment of the MRI field with respect to the CI, it was common practice to remove magnets for high resolution MRI examinations, requiring out-patient surgery and interrupting the patient’s hearing during the process.

With the HiRes Ultra 3D, AB developed new multi-magnet technology that is compatible with MRI scans, giving CI wearers the peace of mind for any current and future health issues that may necessitate an MRI examination. Furthermore, the multi-magnet assembly is designed to withstand repeated exposure to MRI procedures without any loss of magnetic strength or mobility of the magnet assembly components.

 

About Advanced Bionics

Advanced Bionics is a global leader in developing hearing solutions for individuals with severe-to-profound hearing loss who no longer benefit from hearing aids. Founded in 1993 and a subsidiary of the Sonova Group since 2009, AB develops cutting-edge cochlear implant technology that allows recipients to hear their best. AB joined Phonak as part of the Sonova Group of companies and began a collaboration unlike any other in the industry. Since then, the innovation leaders in cochlear implants and hearing aids have continuously combined technologies to deliver new, unequalled hearing solutions. With sales in more than 50 countries and a proven track record for developing high-performing, state-of-theart products, AB’s talented worldwide group of technologists and professionals are driven to engage with patients and professionals, work with integrity, and stay firmly committed to the best possible performance.

 

About Medtech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is an independent program devoted to honoring excellence in medical and health related technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough health and medical companies and products in categories that include Patient Engagement, mHealth, Health & Fitness, Clinical Administration, Healthcare IoT, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com.
 

See the Press Release here
 

Media Contact

Olivia Duarte
Advanced Bionics
661.362.1400
MediaInquiries@AdvancedBionics.com

Read More
Jun 05, 2019

Advanced Bionics announces that their patented HiRes™ Ultra 3D Cochlear Implant has been awarded the Medtech Breakthrough Award 2019 for Best Overall Medical Device Solution.

  



Valencia, CA, June 5, 2019 – Advanced Bionics (AB) announces that their patented HiRes™ Ultra 3D Cochlear Implant has been awarded the Medtech Breakthrough Award 2019 for Best Overall Medical Device Solution.
Built on the HiRes™ Ultra platform and developed by the internal Research and Development Team at AB, the new implant is the Hassle Free and Pain Free choice for recipients who may need to undergo MRI examinations at some point during their lifetime. Even for high resolution MRI scans, there is no need to surgically remove the new multi-magnet assembly and no requirement for head bandaging, meaning no hearing downtime for the patient. 

“We are proud and grateful to receive this prestigious award for the Best Overall Medical Device Solution,” says Victoria Carr-Brendel, PhD, Group Vice President Cochlear Implants (CI), Sonova. “It is a resounding recognition of the ingenuity and hard work of the people at Advanced Bionics over the last years. The new magnet technology in our Ultra 3D implants is improving the quality of life for many of our CI wearers, making MRI scans a hassle-free and pain-free experience.”

The innovative Ultra 3D multi-magnet assembly is capable of aligning with the magnetic field of the MRI scanner irrespective of patient orientation or movement. This allows adult and pediatric cochlear implant wearers to safely undergo high-resolution imaging, such as 3.0 Tesla MRIs, without surgery or head bandaging, without feeling pain or discomfort, and without restrictions to the orientation of the head during the MRI procedure.

MRI examinations are becoming increasingly commonplace as a diagnostic tool for a wide variety of medical conditions. Prior to the development of MRI-compatible CI magnet technology, wearers and healthcare professionals had to contend with the magnetic field from MRI machines exerting force on the CI magnet inside the head, causing torque and subsequent pain. Although these problems were managed to some extent using head bandaging and/or careful alignment of the MRI field with respect to the CI, it was common practice to remove magnets for high resolution MRI examinations, requiring out-patient surgery and interrupting the patient’s hearing during the process.

With the HiRes Ultra 3D, AB developed new multi-magnet technology that is compatible with MRI scans, giving CI wearers the peace of mind for any current and future health issues that may necessitate an MRI examination. Furthermore, the multi-magnet assembly is designed to withstand repeated exposure to MRI procedures without any loss of magnetic strength or mobility of the magnet assembly components.

 

About Advanced Bionics

Advanced Bionics is a global leader in developing hearing solutions for individuals with severe-to-profound hearing loss who no longer benefit from hearing aids. Founded in 1993 and a subsidiary of the Sonova Group since 2009, AB develops cutting-edge cochlear implant technology that allows recipients to hear their best. AB joined Phonak as part of the Sonova Group of companies and began a collaboration unlike any other in the industry. Since then, the innovation leaders in cochlear implants and hearing aids have continuously combined technologies to deliver new, unequalled hearing solutions. With sales in more than 50 countries and a proven track record for developing high-performing, state-of-theart products, AB’s talented worldwide group of technologists and professionals are driven to engage with patients and professionals, work with integrity, and stay firmly committed to the best possible performance.

 

About Medtech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is an independent program devoted to honoring excellence in medical and health related technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough health and medical companies and products in categories that include Patient Engagement, mHealth, Health & Fitness, Clinical Administration, Healthcare IoT, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com.
 

See the Press Release here
 

Media Contact

Olivia Duarte
Advanced Bionics
661.362.1400
MediaInquiries@AdvancedBionics.com

Read more
Mar 18, 2019

Advanced Bionics Starts 2019 Strong with Innovations Benefiting Consumers and Professionals

The leader in cochlear implants releases exciting product upgrades to meet the needs of the marketplace.

VALENCIA, Calif., March 18, 2019 – Advanced Bionics (AB) demonstrates its commitment to their customers and hearing professionals by announcing a wide range of product enhancements to their innovative hearing solutions. Among these are the Naida™ CI Connect receiver, the Chorus™ sound processor and the SoundWave™ 3.2 programming software.


Naída CI Connect lets the wearer stay connected with their world simply and seamlessly. Hands-free phone calls and direct audio streaming are a part of everyday modern life that cochlear implant wearers should enjoy too. Naída CI Connect, one of the most exciting innovations Advanced Bionics developed together with Phonak, is an elegant, design-integrated solution which turns the Naída CI Q90 sound processor into a Bluetooth® wireless headset. With built-in microphones for hands-free calling, and compatibility with virtually all Bluetooth-enabled tablets, laptops, and MP3 players, the Naída CI Connect allows cochlear implant wearers to take hands-free phone calls and stream audio directly from any device.

Chorus brings unprecedented convenience and performance to our first generation implant recipients. The Chorus sound processor is an all new sound processor for the earliest Advanced Bionics patients. Chorus stays charged all-day thanks to an all-new battery design, minimizing the hassle of battery changes. The integrated Roger™ Technology allows transmission of a speaker’s voice via a Roger™ microphone directly to the listener, providing outstanding speech understanding in noise and over distance such as busy restaurants or family gatherings. Chorus even comes with a protective case which allows active wearers to hear and stream music in confidence, even in situations with excessive water, mud, or dirt. With Chorus, the first-generation implant recipients can hear all day, anywhere.

SoundWave 3.2 software enables hearing professionals to provide improved fittings in less time. This new edition of SoundWave meets the demands of busy clinicians dedicated to delivering patient satisfaction. SoundWave 3.2 offers the simplicity professionals want and the flexibility they need, enabling them to connect more with patients while spending less time with software. This latest software upgrade supports all current CI models including the new Chorus sound processor.

“We are excited about the strong rollout of powerful innovations from AB, and we are committed to supporting every Advanced Bionics implant patient as well as new customers along their hearing journey. It’s important that we consult with our patients and professionals to understand their needs and the changes in the overall marketplace. We’re thrilled about where we are headed this year and you can bet on seeing more from us as the year unfolds,” stated Hansjuerg Emch, Group Vice President Cochlear Implants (CI), Sonova.

 

About Advanced Bionics

Advanced Bionics is a global leader in developing hearing solutions for individuals with severe-to-profound hearing loss who no longer benefit from hearing aids. Founded in 1993 and a subsidiary of the Sonova Group since 2009, AB develops cutting-edge cochlear implant technology that allows recipients to hear their best. AB joined Phonak as part of the Sonova Group of companies and began a collaboration unlike any other in the industry. Since then, the innovation leaders in cochlear implants and hearing aids have continuously combined technologies to deliver new, unequalled hearing solutions.

With sales in more than 50 countries and a proven track record for developing high-performing, state-of-the-art products, AB’s talented worldwide group of technologists and professionals are driven work with integrity, engage with patients and professionals, and stay firmly committed to the best possible performance.

 

*Not all products are available in all regions, please check with your local AB representative about product approval and availability in your region.
Bluetooth® is a registered trademark owned by the Bluetooth SIG, Inc.

 

Media Contact

Olivia Duarte
Advanced Bionics
661.362.1400
MediaInquiries@AdvancedBionics.com

Read more
Mar 07, 2019

Advanced Bionics Kicks Off 2019 with Introduction of Wireless Connectivity Accessory

The leader in cochlear implants releases new wireless receiver to connect their wearers with the world simply and seamlessly.


VALENCIA, Calif., March 7, 2019 – Advanced Bionics (AB) demonstrates its commitment to enriching the lives of their wearers with the release of the new Naída™ CI Connect receiver. Hands-free phone calls and direct audio streaming are a part of everyday modern life that cochlear implant wearers should enjoy too. Naída CI Connect, one of the most exciting innovations Advanced Bionics developed together with Phonak, is an elegant, design-integrated solution which turns the Naída CI Q90 sound processor into a Bluetooth® wireless headset. With built in microphones for hands-free calling, and compatibility with virtually all Bluetooth-enabled tablets, laptops, and MP3 players, the Naída CI Connect allows cochlear implant wearers to take hands-free phone calls and stream audio directly from virtually any device.

“We are excited about the introduction of Naída CI Connect because we are committed to supporting every Advanced Bionics implant wearer as well as new customers along their hearing journey. For us, this journey doesn’t end as soon as the implant is activated. Our goal is not only to bring our CI wearers into the world of sound, but also to empower them to enjoy their lives to the fullest. And this second part is what the Naida CI Connect is about. This is also the first product we’re launching in 2019, and we’re thrilled about where we’re headed. You can bet on seeing more from us as the year unfolds,” stated Hansjuerg Emch, Group Vice President Cochlear Implants (CI), Sonova.

 

About Advanced Bionics

Advanced Bionics is a global leader in developing hearing solutions for individuals with severe-to-profound hearing loss who no longer benefit from hearing aids. Founded in 1993 and a subsidiary of the Sonova Group since 2009, AB develops cutting-edge cochlear implant technology that allows recipients to hear their best. AB joined Phonak as part of the Sonova Group of companies and began a collaboration unlike any other in the industry. Since then, the innovation leaders in cochlear implants and hearing aids have continuously combined technologies to deliver new, unequalled hearing solutions.

With sales in more than 50 countries and a proven track record for developing high-performing, state-of-the-art products, AB’s talented worldwide group of technologists and professionals are driven work with integrity, engage with patients and professionals, and stay firmly committed to the best possible performance.

 

Bluetooth® is a registered trademark owned by the Bluetooth SIG, Inc. 

 

Media Contact

Olivia Duarte
Advanced Bionics
661.362.1400
MediaInquiries@AdvancedBionics.com

Read more
Dec 12, 2018

Now Your Patients can Connect With Us — in Spanish or English

At Advanced Bionics, we’re committed to helping everyone achieve their hearing goals. We can help your patient whether they want to enjoy music, feel more
confident using the phone, or join in conversations with friends and family—even in noisy places.

We have Spanish-language resources dedicated to supporting their journey to better hearing every step of the way.

 

A Personal Guide For Your Patients

At AB, we have bilingual Cochlear Implant Consumer Specialists who are eager to connect with your patient, no matter where they are in the process of getting a cohclear implant. Your patient's specialist will be their guide to all of the services and opportunities we have to offer. They can answer their questions, help them find support materials, even introduce them to other cochlear implant recipients.

 

Spanish Resources

We have three amazing websites, in Spanish, dedicated to helping your patients reach their hearing goals: AdvancedBionics.com/us-es, Caminoaudicion.com online forum and TheListeningRoom.com rehabilitation website.

 

AdvancedBionics.com/us-es

We are excited to announce our new Spanish-language Advanced Bionics website. Connect to AB to learn all about technologically advanced products, explore resources, and more!
 

CaminoAudición

We’re excited to introduce you to CaminoAudición, the Spanish-language version of our thriving HearingJourney™ website. Advanced Bionics developed the site because of our determination to support those who are considering cochlear implants. CaminoAudición is a place to chat, laugh, learn and share stories about hearing loss and cochlear implants. Like HearingJourney, CaminoAudición is a safe, secure online forum of cochlear implant candidates and recipients.

 

The Listening Room

The Listening Room is a one-of-a-kind website that offers engaging, effective rehabilitation exercises that support parents as they help their child learn to hear with a cochlear implant. It is filled with fun, bilingual interactive activities for you to share with patients. You can use the language filter to discover Spanish-language activities to help your patient families with hearing loss learn to listen, develop language and experience music. And don't forget you can connect with your families through the The Listening Room to further support their growth by suggesting activities!

 

We Can’t Wait to Assist Your Patients

Do they need Customer Service, information about Insurance Reimbursement, or a connection to a sympathetic ear? No problem. Our bilingual representatives are there to help.

We have a dedicated Spanish-language resource line and an email just for Spanish speakers. The phone number is 1.833.277.5OIR. The email address: escucha@AdvancedBionics.com.
 

Read more
Aug 30, 2018

AB Introduces Hassle Free MRI Cochlear Implant Technology

Advanced Bionics (AB) announces the FDA Approval of the HiRes™ Ultra 3D Cochlear Implant. Built on the HiRes™ Ultra platform and developed by the internal Research and Development Team at AB, the new implant is the Hassle Free and Pain Free choice for recipients undergoing MRI examinations. Even for high resolution MRI examinations there is no need to remove the magnet and no requirement for head bandaging, meaning no hearing downtime for the patient.


 

Valencia, CA, August 30, 2018 – Advanced Bionics (AB) Announces the FDA Approval of the HiRes™ Ultra 3D Cochlear Implant. Built on the HiRes™ Ultra platform and developed by the internal Research and Development Team at AB, the new implant is the Hassle Free and Pain Free choice for recipients undergoing MRI examinations. Even for high resolution MRI examinations there is no need to remove the magnet and no requirement for head bandaging, meaning no hearing downtime for the patient.

Hansjuerg Emch, Group Vice President Cochlear Implants (CI), Sonova says, “After many years of research and development, the new magnet technology in our cochlear implants will improve the quality of life for our many recipients due to our hassle free and pain free magnet. We are leading the way and ensuring our recipients have the best possible experiences with our advanced technology. It’s a powerful innovation and makes our efforts so rewarding for patients.”

The new magnet design provides alignment with an external magnetic field in any direction. This allows cochlear implant recipients to move freely around in the strong magnetic field of an MRI machine without feeling pain or discomfort, and without restrictions to the orientation of the head.

MRI examinations are already a standard of care for health care professionals and with this in mind AB developed new magnet technology that is compatible with MRI screenings, allowing patients’ peace of mind for any future health issues that necessitate an MRI examination. Previously, patients and surgeons had to contend with the strong magnetic field from MRI machines exerting force on the magnet, causing torque and subsequent pain if the magnet remained in situ, even with head bandaging. Therefore it was common to remove the magnet for high resolution MRI examinations, requiring out-patient surgery and interrupting the patient’s hearing during the healing process. And with the future in mind the new technology has been designed to undergo heavy usage of MRI procedures without any loss of magnetic strength or mobility of the magnet components.

 

About Advanced Bionics

Advanced Bionics is a global leader in developing hearing solutions for individuals with severe-to-profound hearing loss who no longer benefit from hearing aids. Founded in 1993 and a subsidiary of the Sonova Group since 2009, AB develops cutting-edge cochlear implant technology that allows recipients to hear their best. AB joined Phonak as part of the Sonova Group of companies and began a collaboration unlike any other in the industry. Since then, the innovation leaders in cochlear implants and hearing aids have continuously combined technologies to deliver new, unequalled hearing solutions.

AB offers the most capable cochlear implant system on the market1, the HiResolution™ Bionic Ear System designed to help recipients hear in noisy settings and enjoy the full dimensions of music and tonal languages2,3. With sales in more than 50 countries and a proven track record for developing high-performing, state-of-the-art products, AB’s talented worldwide group of technologists and professionals are driven to succeed, work with integrity and stay firmly committed to quality.

 

1. Technical Specifications. HiRes™ Ultra 3D Cochlear Implant. 2018. 028-M960-03 RevB.
2. Adams D, Ajimsha KM, Barberá MT, Gazibegovic D, Gisbert J, Gómez J, Raveh E, Rocca C, Romanet P, Seebens Y, Zarowski A., Multicentre evaluation of music perception in adult users of Advanced Bionics cochlear implants Cochlear Implants Int. 2014 Jan;15(1):20-6. doi: 10.1179/1754762813Y.0000000032. Epub 2013 Nov 25.
3. Chang YT, Yang HM, Lin YH, Liu SH, Wu JL. Tone discrimination and speech perception benefit in Mandarin-speaking children fit with HiRes Fidelity 120 sound processing. Otol Neurotol. 2009 Sep;30(6):750-7. doi: 10.1097/MAO.0b013e3181b286b2.

 

Media Contact

Olivia Duarte
Advanced Bionics
661.362.1400
MediaInquiries@AdvancedBionics.com

 

Read more
Feb 06, 2018

Groundbreaking Microphone Technology to be launched by Phonak and Advanced Bionics

Phonak and Advanced Bionics today announce a breakthrough in new microphone technology, that will help people with hearing aids and cochlear implants hear better especially in noise. The invention is called MultiBeam Technology, which soon will be applied in new advanced wireless microphones. First scientific results with patients show large improvements in speech recognition.    

Stäfa (Switzerland) and Valencia (USA), 6. February 2018 - Phonak and Advanced Bionics today announce a breakthrough in new microphone technology, that will help people with hearing aids and cochlear implants hear better especially in noise. The invention is called MultiBeam Technology, which soon will be applied in new advanced wireless microphones. First scientific results with patients show large improvements in speech recognition.

People with hearing loss use hearing aids or cochlear implants to hear better. Despite huge advancements in these devices, fundamental barriers remain in noisy restaurants, large business meetings or social gatherings, all acoustically challenging environments. There, 31%1 of people with hearing aids still have difficulties following conversations. This can lead to social retreat with further health implications.

Since September 2009 a highly specialized task force of more than 10 digital signal processing and acoustic engineers have been working on the development of MultiBeam Technology. By utilizing multiple microphones in six directions, speech from 360 degrees is calculated and compared. The direction with the best signal-to-noise ratio is automatically selected. The technological processing complexity is almost ten times higher than the previous technology generation from Phonak, and the power consumption was reduced by more than one third at the same time.

In a scientific investigation at the University of Texas in Dallas a group of 10 patients with hearing aids were tested in a situation which resembled a noisy restaurant or very noisy meeting with three conversation partners (see Figure 1). Speech understanding improves up to 61% in this group conversation in 75 dBA of noise compared to using hearing aids alone.2 Professor Linda Thibodeau, from the University of Texas in Dallas who led the research, says: “The Multibeam Technology will allow persons with hearing challenges who have resigned from attending social functions, family gatherings and business meetings to experience significant improvements in speech recognition. This could ultimately lead to improved quality of life as they confidently reconnect with others using discreet, convenient and highly versatile technology.”

Hans Mülder, senior audiologist and director marketing at Phonak says: “We are extremely happy to have achieved this milestone. It underlines the unwavering commitment of our finest engineers to never be satisfied with existing solutions but to continue to push the envelope of technology, so that more people can enjoy  their lives to the fullest. We are now working hard to embed the new technology in coming solutions.” 
 

 

 

Figure 1

Illustration of MultiBeam Technology being used
in a group of people in a noisy background

 

About Phonak

In 2017, Phonak, a member of the Sonova Group, proudly celebrates its 70th anniversary.

Headquartered near Zurich, Switzerland, Phonak was born in 1947 out of a passion for taking on the most difficult hearing challenges. Seventy years later, this passion remains. As the industry’s leading provider, we offer the broadest portfolio of life-changing hearing solutions. From pediatric to profound hearing loss, we remain committed to creating hearing solutions that change people’s lives to thrive socially and emotionally. We believe in creating a world where ‘Life is on’ for everyone.

For more information, please visit www.phonak.com, www.phonakpro.com

 

About Advanced Bionics

Advanced Bionics is a global leader in developing the most advanced cochlear implant systems in the world. Founded in 1993 and a subsidiary of the Sonova Group since 2009, AB develops cutting-edge cochlear implant technology that allows recipients to hear their best.

AB offers the most sophisticated cochlear implant system on the market, the HiResolution Bionic Ear System, with five times more sound resolution than its competitors, designed to help recipients hear in noisy settings and enjoy the full dimensions of music.

With sales in over 50 countries and a proven track record for developing high-performing, state-of-the-art products, AB’s talented group of technologists and professionals from all over the world are driven to succeed, work with integrity and stay firmly committed to quality.

To learn more about AB and its innovative cochlear implant technology, please visit www.AdvancedBionics.com
 

Media Relations Contacts:

U.S.


John Urbaniak
Phone + 1 331 204 27 99
Email John.Urbaniak@Sonova.com

 


Olivia Duarte
Phone +1 661 362 14 00
Email MediaInquiries@AdvancedBionics.com

Europe


Patrick Lehn
Phone +41 58 928 33 23
Mobile +41 79 410 82 84
Email Patrick.Lehn@Sonova.com
 
 

Asia/Pacific

Heidi Zhang
Phone   +86 1300 1271 545

Mobile +86 13001271545

Email   Heidi.Zhang@Sonova.com

 

 

¹ Abrams, H. B., & Kihm, J. (2015). An Introduction to MarkeTrak IX: A New Baseline for the Hearing Aid Market. Hearing Review, 22(6), 16.

² Based on preliminary data. Peer-reviewed article and Field Study News in preparation, available end of 2018 at www.phonakpro.com/evidence.

 

Read more